|
Market Closed -
NSE India S.E.
12:05:08 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.020 INR | +1.35% |
|
-5.55% | -8.15% |
Company Valuation: JHS Svendgaard Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,288 | 1,334 | 1,006 | 1,266 | 957.1 | 572.5 |
| Change | - | 3.55% | -24.57% | 25.86% | -24.41% | -40.18% |
| Enterprise Value (EV) 1 | 1,128 | 1,315 | 770.7 | 1,216 | 836.5 | 548.6 |
| Change | - | 16.63% | -41.41% | 57.78% | -31.21% | -34.42% |
| P/E | 102x | -32.6x | -6.62x | -8.19x | -4.71x | -29.3x |
| PBR | 0.68x | 0.72x | 0.58x | 0.75x | 0.55x | 0.33x |
| PEG | - | 0x | -0x | 0.5x | -0.2x | 0.3x |
| Capitalization / Revenue | 1.28x | 1.55x | 0.98x | 1.74x | 1.04x | 0.56x |
| EV / Revenue | 1.12x | 1.52x | 0.75x | 1.67x | 0.91x | 0.54x |
| EV / EBITDA | 18.6x | 93.7x | -67.8x | 95x | -23.5x | 18.6x |
| EV / EBIT | 317x | -28.6x | -11x | -26.8x | -7.69x | -13.7x |
| EV / FCF | -248x | 6.65x | 1.85x | -3.77x | -7.82x | -4.64x |
| FCF Yield | -0.4% | 15% | 54% | -26.5% | -12.8% | -21.5% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.1952 | -0.63 | -2.34 | -1.973 | -2.374 | -0.2238 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1,010 | 862.5 | 1,026 | 728.9 | 922.9 | 1,017 |
| EBITDA 1 | 60.48 | 14.03 | -11.37 | 12.8 | -35.67 | 29.51 |
| EBIT 1 | 3.554 | -46.05 | -69.82 | -45.42 | -108.8 | -39.9 |
| Net income 1 | 11.98 | -40.52 | -154.6 | -154.6 | -197.4 | -19.22 |
| Net Debt 1 | -160.3 | -18.37 | -235.3 | -50.11 | -120.6 | -23.92 |
| Reference price 2 | 20.000 | 20.550 | 15.500 | 16.150 | 11.180 | 6.550 |
| Nbr of stocks (in thousands) | 64,400 | 64,900 | 64,900 | 78,397 | 85,604 | 87,406 |
| Announcement Date | 06/09/21 | 09/09/22 | 05/09/23 | 16/08/24 | 28/08/25 | 02/09/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 8.31M | |
| 23.42x | 4.44x | 16.27x | 2.76% | 370B | |
| 31.25x | 4.79x | 19.77x | 1.91% | 244B | |
| 19.62x | 2.91x | 12.84x | 3.22% | 143B | |
| 25.95x | 3.81x | 16.04x | 2.28% | 75.02B | |
| 56.38x | 7.98x | 30.77x | 0.28% | 49.83B | |
| 39.27x | 6.33x | 27.49x | 2.38% | 46.88B | |
| 35.95x | 2.71x | 15.03x | 1.48% | 37.82B | |
| 19.92x | 2.78x | 11.61x | 4.46% | 36.32B | |
| 15.92x | 2.42x | 11.33x | 4.88% | 35.11B | |
| Average | 29.74x | 4.24x | 17.91x | 2.63% | 103.78B | |
| Weighted average by Cap. | 27.30x | 4.33x | 17.43x | 2.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- JHS Stock
- Valuation JHS Svendgaard Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
